BALTIMORE - A dosage mix-up at a Baltimore production facility, which ruined about 15 million doses of Johnson & Johnson’s COVID vaccine, has prompted the U.S.
Food and Drug Administration to delay certification of the facility.Employees at Emergent BioSolutions, a production facility in Baltimore, and a manufacturing partner to Johnson & Johnson and AstraZeneca, reportedly mixed-up two vaccine dosages and shipments were put on hold.Shipments of Johnson & Johnson’s vaccine have been delayed pending an investigation by the FDA.RELATED: Thousands of COVID-19 vaccine doses lost to spoilage or discarded across USUS officials said the vaccine spoilage will not impact plans to provide enough vaccine to immunize every adult by May.In a statement.